2020•Nigerian Journal of Pharmaceutical and Applied Science ResearchOpen access

Effects of Coadministration of Vitamin C and Lamotrigine on some Pharmacological Properties of Lamotrigine in Laboratory Animals

Muhammad Shamsuddeen Yusuf, Sani Abubakar Malami, Nuhu Muhammad Danjuma, Hadiza Mai’adua Salisu, Jibril Kabir Dogara, Nuhu Aliyu Bako, Abdulkadir Muhammad Kabiru

Open full text 0 citations

Abstract

Despite the continued development and release of new antiepileptic drugs, many patients have seizures that do not respond to drug therapy or have related side effects that preclude continued use. The present study is aimed at establishing the possible potentiation actions of vitamin C on the anticonvulsant effects of lamotrigine in acute and chronic seizure models and on the possible prevention and/or reversal of haematological side effects of lamotrigine.This aim was achieved using maximal electroshock test (MEST)-induced seizure model for which the method of Swinyard and Kupferberg, (1985) was adopted, pentylenetetrazole-induced kindling model for which method described by Gupta et al., (2001) was employed and haematological analysis in which haemoglobin concentration, packed cell volume, red blood cell count, white blood cell count / differentials and platelets count were carried out. Lamotrigine and Vitamin C combination at doses of 50 mg/kg, 100 mg/kg and 400 mg/kg provided 16.67%, 50%, and 66.67% protection respectively against MEST-induced seizures. There was no significant (p < 0.05) difference in the mean recovery period. Lamotrigine only showed 0% protection against MEST-induced seizures. In PTZ induced kindling, Vitamin C (50 mg/kg and 400 mg/kg) showed a significant (p < 0.05) reduction (from 5.00 to 0.88 and 5.00 to 2.13 respectively) in the severity of seizure induced by sub-convulsive dose (35 mg/kg) of PTZ as compared to control group on day ten. Administration of lamotrigine caused a reduction in mean neutrophils count as against untreated control group. Addition of vitamin C (50 mg/kg and 100 mg/kg) to lamotrigine treated group caused an increase in neutrophils compared to lamotrigine only treated group. The results showed that vitamin C enhances the anticonvulsant and some haematological sideeffects of lamotrigine, thus may serve as an adjunct in treatment of epilepsy using lamotrigine.

About this research paper

What this paper is about

Despite the continued development and release of new antiepileptic drugs, many patients have seizures that do not respond to drug therapy or have related side effects that preclude continued use. The present study is aimed at establishing the possible potentiation actions of vitamin C on the anticonvulsant effects of lamotrigine in acute and chronic seizure models and on the possible prevention and/or reversal of haematological side effects of lamotrigine.This aim was achieved using maximal electroshock test (MEST)-induced seizure model for which the method of Swinyard and Kupferberg, (1985) was adopted, pentylenetetrazole-induced kindling model for which method described by Gupta et al., (2001) was employed and haematological analysis in which haemoglobin concentration, packed cell volume, red blood cell count, white blood cell count / differentials and platelets count were carried out. Lamotrigine and Vitamin C combination at doses of 50 mg/kg, 100 mg/kg and 400 mg/kg provided 16.67%, 50%, and 66.67% protection respectively against MEST-induced seizures. There was no significant (p < 0.05) difference in the mean recovery period. Lamotrigine only showed 0% protection against MEST-induced seizures. In PTZ induced kindling, Vitamin C (50 mg/kg and 400 mg/kg) showed a significant (p < 0.05) reduction (from 5.00 to 0.88 and 5.00 to 2.13 respectively) in the severity of seizure induced by sub-convulsive dose (35 mg/kg) of PTZ as compared to control group on day ten. Administration of lamotrigine caused a reduction in mean neutrophils count as against untreated control group. Addition of vitamin C (50 mg/kg and 100 mg/kg) to lamotrigine treated group caused an increase in neutrophils compared to lamotrigine only treated group. The results showed that vitamin C enhances the anticonvulsant and some haematological sideeffects of lamotrigine, thus may serve as an adjunct in treatment of epilepsy using lamotrigine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Despite the continued development and release of new antiepileptic drugs, many patients have seizures that do not respond to drug therapy or have related side effects that preclude continued use. The present study is aimed at establishing the possible potentiation actions of vitamin C on the anticonvulsant effects of lamotrigine in acute and chronic seizure models and on the possible prevention and/or reversal of haematological side effects of lamotrigine.This aim was achieved using maximal electroshock test (MEST)-induced seizure model for which the method of Swinyard and Kupferberg, (1985) was adopted, pentylenetetrazole-induced kindling model for which method described by Gupta et al., (2001) was employed and haematological analysis in which haemoglobin concentration, packed cell volume, red blood cell count, white blood cell count / differentials and platelets count were carried out. Lamotrigine and Vitamin C combination at doses of 50 mg/kg, 100 mg/kg and 400 mg/kg provided 16.67%, 50%, and 66.67% protection respectively against MEST-induced seizures. There was no significant (p < 0.05) difference in the mean recovery period. Lamotrigine only showed 0% protection against MEST-induced seizures. In PTZ induced kindling, Vitamin C (50 mg/kg and 400 mg/kg) showed a significant (p < 0.05) reduction (from 5.00 to 0.88 and 5.00 to 2.13 respectively) in the severity of seizure induced by sub-convulsive dose (35 mg/kg) of PTZ as compared to control group on day ten. Administration of lamotrigine caused a reduction in mean neutrophils count as against untreated control group. Addition of vitamin C (50 mg/kg and 100 mg/kg) to lamotrigine treated group caused an increase in neutrophils compared to lamotrigine only treated group. The results showed that vitamin C enhances the anticonvulsant and some haematological sideeffects of lamotrigine, thus may serve as an adjunct in treatment of epilepsy using lamotrigine.

Key concepts: Lamotrigine, Anticonvulsant, Pharmacology, Medicine, Convulsant, Vitamin, Epilepsy, Kindling

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Coadministration of Vitamin C and Lamotrigine on some Pharmacological Properties of Lamotrigine in Laboratory Animals — Research Paper | ScholarLens